AN UPDATE ON THE OVERALL SAFETY AND INCIDENCE OF SPM IN LENALIDOMIDE-, THALIDOMIDE-, AND BORTEZOMIB-TREATED PATIENTS WITHIN THE EUROPEAN POST-APPROVAL SAFETY STUDY (EU PASS) OF RELAPSED/REFRACTORY MM
HAEMATOLOGICA(2012)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要